- Scheme Category:
- Other Scheme >
- Index Funds
NAV: ₹ ↑ 0.41%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth and its peers as on 10 August, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth | 15.72% | 0.41% | 1.01% | 3.22% | 12.63% | 26.31% | 19.5% | 13.91% | - | - |
| SBI NIFTY INDEX FUND - DIRECT PLAN - GROWTH | -5.27% | 0.05% | -0.75% | 1.76% | 2.4% | 1.85% | 8.96% | 9.61% | 12.91% | 12.03% |
| SBI Nifty Next 50 Index Fund - Direct Plan - Growth | 7.87% | 0.09% | 0.25% | 3.51% | 4.89% | 14.83% | 19.29% | 14.24% | - | - |
| SBI CPSE Bond Plus SDL Sep 2026 50:50 Index Fund - Direct Plan - Growth | 3.63% | 0.05% | 0.11% | 0.49% | 1.55% | 5.98% | 7.22% | - | - | - |
| SBI CRISIL IBX Gilt Index - April 2029 Fund - Direct Plan - Growth | 3.17% | 0.06% | 0.32% | 0.53% | 1.95% | 5.54% | 7.8% | - | - | - |
| SBI |CRISIL IBX Gilt Index - June 2036 Fund - Direct Plan - Growth | 3.83% | 0.03% | 0.72% | 0.07% | 3.26% | 5.49% | 7.95% | - | - | - |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | - | - | 16.96% | -3.92% | 27.42% | 27.77% | 5.49% |
Discrete returns (monthly)
| Month | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | 1.42% | 3.83% | -0.71% | -2.51% | 5.16% | -4.55% | 2.98% | 2.43% | 7.08% | 4.05% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 99.50% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 0.50% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 11.73% |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 5.59% |
| Max Healthcare Institute Ltd. | MAXHEALTH (INE027H01010) | Healthcare Services | 5.30% |
| Divi's Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 5.08% |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 4.84% |
| Dr. Reddy's Laboratories Ltd. | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 4.76% |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 4.13% |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 3.55% |
| Fortis Healthcare Ltd. | FORTIS (INE061F01013) | Healthcare Services | 2.77% |
| Laurus Labs Ltd. | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 2.44% |
| Aurobindo Pharma Ltd. | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 2.37% |
| Glenmark Pharmaceuticals Ltd. | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 2.27% |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 1.79% |
| Mankind Pharma Ltd. | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 1.72% |
| Biocon Ltd. | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 1.55% |
| IPCA Laboratories Ltd. | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 1.53% |
| Zydus Lifesciences Ltd. | ZYDUSLIFE (INE010B01027) | Pharmaceuticals & Biotechnology | 1.23% |
| JB Chemicals & Pharmaceuticals Ltd. | JBCHEPHARM (INE572A01036) | Pharmaceuticals & Biotechnology | 1.19% |
| Aster DM Healthcare Ltd. | ASTERDM (INE914M01019) | Healthcare Services | 1.05% |
| Ajanta Pharma Ltd. | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 0.89% |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 0.87% |
| Narayana Hrudayalaya ltd. | NH (INE410P01011) | Healthcare Services | 0.82% |
| GlaxoSmithKline Pharmaceuticals Ltd. | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 0.70% |
| Global Health Ltd. | MEDANTA (INE474Q01031) | Healthcare Services | 0.55% |
| Emcure Pharmaceuticals Ltd. | EMCURE (INE168P01015) | Pharmaceuticals & Biotechnology | 0.31% |
| ELI LILLY & CO | (US5324571083) | Pharmaceuticals | 5.72% |
| JOHNSON & JOHNSON | (US4781601046) | Pharmaceuticals | 4.52% |
| ABBVIE INC | (US00287Y1091) | Biotechnology | 2.95% |
| MERCK & CO.INC | (US58933Y1055) | Pharmaceuticals | 2.29% |
| NOVARTIS AG | (US66987V1098) | Pharmaceuticals | 2.23% |
| AMGEN INC | (US0311621009) | Biotechnology | 1.45% |
| THERMO FISHER SCIENTIFIC INC | (US8835561023) | Life Sciences Tools & Services | 1.41% |
| ABBOTT LABORATORIES | (US0028241000) | Health Care Equipment & Supplies | 1.36% |
| GILEAD SCIENCES INC | (US3755581036) | Biotechnology | 1.33% |
| INTUITIVE SURGICAL INC | (US46120E6023) | Health Care Equipment & Supplies | 1.26% |
| DANAHER CORP | (US2358511028) | Health Care Equipment & Supplies | 0.93% |
| Novo Nordisk A/S | (US6701002056) | Pharmaceuticals & Biotechnology | 0.91% |
| STRYKER CORP | (US8636671013) | Health Care Equipment & Supplies | 0.87% |
| VERTEX PHARMACEUTICALS INC | (US92532F1003) | Biotechnology | 0.87% |
| MEDTRONIC PLC | (IE00BTN1Y115) | Health Care Equipment & Supplies | 0.85% |
| Regeneron Pharmaceuticals Inc | (US75886F1075) | Pharmaceuticals | 0.63% |
| BECTON DICKINSON AND CO | (US0758871091) | Health Care Equipment & Supplies | 0.34% |
| AGILENT TECHNOLOGIES INC | (US00846U1016) | Life Sciences Tools & Services | 0.25% |
| IQVIA HOLDINGS INC | (US46266C1053) | Life Sciences Tools & Services | 0.21% |
| WATERS CORP | (US9418481035) | Pharmaceuticals | 0.09% |
Portfolio data is as on date 31 March, 2026
NAV history
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 10 August, 2026 | 24.8021 | 0.41% |
| 7 August, 2026 | 24.7019 | 0.37% |
| 6 August, 2026 | 24.6098 | 0.17% |
| 5 August, 2026 | 24.5691 | 0.27% |
| 4 August, 2026 | 24.503 | -0.21% |
| 3 August, 2026 | 24.5534 | -0.15% |
| 31 July, 2026 | 24.5908 | -0.17% |
| 30 July, 2026 | 24.6318 | -0.61% |
| 29 July, 2026 | 24.7838 | 0.69% |
| 28 July, 2026 | 24.6137 | 0.66% |
| 27 July, 2026 | 24.4524 | 1.09% |
| 24 July, 2026 | 24.1882 | 0% |
| 23 July, 2026 | 24.1883 | 0.32% |
| 22 July, 2026 | 24.1113 | -0.84% |
| 21 July, 2026 | 24.3151 | 0.31% |
| 20 July, 2026 | 24.2403 | 0.45% |
| 17 July, 2026 | 24.1326 | -0.78% |
| 16 July, 2026 | 24.3214 | 0.69% |
| 15 July, 2026 | 24.1548 | 0.46% |
| 14 July, 2026 | 24.0445 | 0.06% |
| 13 July, 2026 | 24.0289 | 0% |
| 10 July, 2026 | 24.0278 | -0.16% |
| 9 July, 2026 | 24.0662 | 0.67% |
| 8 July, 2026 | 23.9067 | -1.3% |
| 7 July, 2026 | 24.2207 | -0.03% |
| 6 July, 2026 | 24.228 | 0.93% |
| 2 July, 2026 | 24.0055 | 1.58% |
| 1 July, 2026 | 23.6332 | -0.34% |
| 30 June, 2026 | 23.7138 | -0.14% |
| 29 June, 2026 | 23.7461 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The latest NAV of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth is 24.8021 as on 10 August, 2026.What are YTD (year to date) returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The YTD (year to date) returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth are 15.72% as on 10 August, 2026.What are 1 year returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The 1 year returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth are 26.31% as on 10 August, 2026.What are 3 year CAGR returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The 3 year annualized returns (CAGR) of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth are 19.5% as on 10 August, 2026.What are 5 year CAGR returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The 5 year annualized returns (CAGR) of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth are 13.91% as on 10 August, 2026.